- Title
- Do gabapentin or pregabalin directly modulate the µ receptor?
- Creator
- Manandhar, Preeti; Murnion, Bridin Patricia; Grimsey, Natasha L.; Connor, Mark; Santiago, Marina
- Relation
- PeerJ Vol. 9, Issue 12 April 2021, no. e11175
- Publisher Link
- http://dx.doi.org/10.7717/peerj.11175
- Publisher
- PeerJ
- Resource Type
- journal article
- Date
- 2021
- Description
- Background: Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in opioid related deaths, however, the molecular mechanism behind this is still unclear. We have sought to determine whether pregabalin or gabapentin directly modulates acute μ receptor signaling, or μ receptor activation by morphine. Methods: The effects of pregabalin and gabapentin were assessed in HEK 293 cells stably transfected with the human μ receptor. Their effect on morphine induced hyperpolarization, cAMP production and ERK phosphorylation were studied using fluorescent-based membrane potential assay, bioluminescence based CAMYEL assay and ELISA assay, respectively. Pregabalin/gabapentin effects on morphine-induced hyperpolarization were also investigated in AtT20 cells. Results: Pregabalin or gabapentin (1 µM, 100 µM each) did not activate the µ receptor or affect K channel activation or ERK phosphorylation produced by morphine. Neither drug affected the desensitization of K channel activation produced by prolonged (30 min) application of morphine. Gabapentin (1 µM, 100 µM) and pregabalin (1 µM) did not affect inhibition of forskolin-stimulated cAMP production by morphine. However, pregabalin (100 µM) potentiated forskolin mediated cAMP production, although morphine still inhibited cAMP levels with a similar potency to control. Discussion: Pregabalin or gabapentin did not activate or modulate µ receptor signaling in three different assays. Our data do not support the hypothesis that gabapentin or pregabalin augment opioid effects through direct or allosteric modulation of the µ receptor. Pregabalin at a high concentration increases cAMP production independent of morphine. The mechanism of enhanced opioid-related harms from co-ingestion of pregabalin or gabapentin with opioids needs further investigation.
- Subject
- pregabalin; gabapentin; Sustainable Development Goals; opioid; u receptor; overdose; gabapentinoids; morphine; opioid-related harm; opioid receptor signaling; SDG 3
- Identifier
- http://hdl.handle.net/1959.13/1456566
- Identifier
- uon:45242
- Identifier
- ISSN:2167-8359
- Rights
- © Copyright 2021 Manandhar et al. Distributed under Creative Commons CC-BY 4.0
- Language
- eng
- Full Text
- Reviewed
- Hits: 2752
- Visitors: 2807
- Downloads: 62
Collections
Goal 3: Good Health and Well-Being
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | ATTACHMENT02 | Publisher version (open access) | 2 MB | Adobe Acrobat PDF | View Details Download |